Ambrx Biopharma, Inc.
AMAMCIK 0001990550 · Every Form 4 filed by insiders at this issuer.
Filings
8
Latest Mar 7, 2024
Unique insiders
8
Showing
8 of 8
Page 1
Top insiders
Most active reporters at Ambrx Biopharma, Inc.
| Name | Roles | Filings |
|---|---|---|
| Aromando Andrew | Officer | 1 |
| DALESANDRO MARGARET | Director | 1 |
| Glover Stephen C. | Director | 1 |
| Hermans Kate | Director | 1 |
| Loesberg Janet | Director | 1 |
| MAIER PAUL V | Director | 1 |
| Nelson Sonja | Officer | 1 |
| O'Connor Daniel J. | OfficerDirector | 1 |
All filings
8 Form 4 / 4-A filings, newest first
| Filed | Insider | Top transaction | Shares | Price | Value | |
|---|---|---|---|---|---|---|
| Mar 7, 2024 | MAIER PAUL V Director | Holdings only | — | — | — | |
| Mar 7, 2024 | DALESANDRO MARGARET Director | Holdings only | — | — | — | |
| Mar 7, 2024 | Nelson Sonja Chief Financial Officer | D | 22,936 | — | — | |
| Mar 7, 2024 | Aromando Andrew Chief Operating Officer | Holdings only | — | — | — | |
| Mar 7, 2024 | Glover Stephen C. Director | Holdings only | — | — | — | |
| Mar 7, 2024 | O'Connor Daniel J. President and CEO · Director | D | 48,202 | — | — | |
| Mar 7, 2024 | Loesberg Janet Director | Holdings only | — | — | — | |
| Mar 7, 2024 | Hermans Kate Director | Holdings only | — | — | — |
Showing 1–8 of 8
Page 1 of 1
Real-time Form 4 intelligence. Smarter insider tracking.